Celestica Q1: AI Revenue Soars While The Stock Plunges, I'm Buying

Celestica posted a strong quarter with 53% year-over-year revenue growth, led by hyperscaler data center demand, while CCS revenue rose 76% and margins expanded to 10.8%. The company beat expectations and raised guidance, reinforcing a positive fundamental outlook. Despite the earnings strength, shares fell 14% premarket on sentiment and positioning rather than operating performance.

Analysis

CLS is increasingly functioning as a leveraged proxy for hyperscaler capex rather than a generic EMS name, which matters because the market is still pricing the stock off a more cyclical hardware multiple. That creates a second-order setup: if AI infrastructure spend stays even moderately resilient, CLS can keep compounding revenue faster than peers while mix shift into higher-value data center programs supports incremental margin capture. The key implication is that the company’s earnings power may be rerating faster than the shares, especially after a sentiment-driven air pocket.

The near-term loser is anyone shorting the stock purely on “good news already priced in” logic; premarket weakness after an upside print often reflects positioning rather than fundamental deterioration, and that tends to resolve over days, not quarters. More broadly, competitors with lower exposure to AI-related end markets may look cheaper on reported multiples but are actually facing slower growth and less operating leverage, which makes relative valuation screens misleading if the market re-anchors to growth. Supply-chain beneficiaries in adjacent high-mix electronics manufacturing could also see a halo effect as customers prioritize trusted capacity for AI deployments.

The main risk is that the current re-rating thesis depends on hyperscaler demand staying intact into the next budget cycle; if big cloud spend pauses for even one quarter, CLS’s multiple can compress faster than estimates fall. Another risk is margin disappointment: at this stage, investors will care more about whether margins keep trending up than about top-line growth alone, because that is what justifies PEG-based upside. Time horizon matters: the move can remain dislocated for days from sentiment, but the fundamental rerate should play out over 3-6 months if guidance keeps stepping up.

Consensus is probably underestimating how much of CLS’s value is coming from operating leverage on AI infrastructure content, not just headline growth. The market seems focused on the premarket selloff and treating it as a warning sign, when it may actually be an entry point if the stock is still below its forward-growth-adjusted fair value. If management can show another quarter of stable-to-improving margins, the bear case loses its most important objection.

Key Decisions for Investors

• Go long CLS on post-open weakness if volume confirms capitulation; use a 3-6 month horizon and target a re-rating toward peer growth multiples, with downside protected by the raised guidance backdrop.
• Buy CLS call spreads 1-2 quarters out to express upside from multiple expansion without taking full delta risk; best risk/reward if implied vol stays elevated after the selloff.
• Pair trade: long CLS / short a slower-growth industrial-tech or EMS peer with less AI exposure over the next 1-2 quarters to isolate the hyperscaler growth premium.
• If already long, trim only on a fast move back to pre-print levels and hold the core for another guide-up cycle; the thesis breaks only if hyperscaler demand or gross margin trajectory rolls over.